In:
French-Ukrainian Journal of Chemistry, Taras Shevchenko National University of Kyiv, Vol. 5, No. 1 ( 2017), p. 24-34
Kurzfassung:
A recently proposed "ethynylogation" pharmacochemical approach, first envisaged in the series of anticancer lipidic dialkynylcarbinols (DACs) H–C≡C–CH(OH)–C≡C–R at the levels of the H–C⋮ and ⋮C–R bonds for R = n-C12H25, is completed here at the level of the (HO)C–H bond. The so-devised mono-lipidic trialkynylcarbinol (TAC) target (HC≡C)2C(OH)–C≡CR and its bis-lipidic counterpart HC≡C–C(OH)(C≡CR)2 were synthesized in 4 steps and with 33 % and 23 % overall yield, respectively. Their antitumor cytotoxicity has been evaluated towards HCT116 cells: while the latter TAC is totally inactive, the former DAC-ethynylogous TAC still exhibits a significant toxicity with an IC50 of 10 µM.
Materialart:
Online-Ressource
ISSN:
2312-3222
DOI:
10.17721/fujcV5I1P24-34
Sprache:
Englisch
Verlag:
Taras Shevchenko National University of Kyiv
Publikationsdatum:
2017
ZDB Id:
2921413-0